northwindkate

About Kate Lagreca

This author has not yet filled in any details.
So far Kate Lagreca has created 25 blog entries.

Workshop in Holyoke informs community on college finances

The Massachusetts Society of Certified Public Accountants held a “You Can Afford College” workshop Thursday in Holyoke. The event is part of a new statewide initiative focused on informing students and parents about resources available to help them pay for college. Holyoke State Representative Aaron Vega (D) is partnering with the organization. He hopes workshops [...]

October 14th, 2016|WWLP 22 News|

Walsh hits a chord with business leaders with call for diversity

Mayor Martin J. Walsh looked across the hotel ballroom at a sea of white faces. And then he took to the podium at the business breakfast and devoted more than a third of his annual address to a subject that rarely gets openly discussed in these circles: race in corporate Boston. He challenged business leaders [...]

October 13th, 2016|The Boston Globe|

The Work Behind Construction Projects

Just before the Great Recession, the U.S. construction industry was booming. In 2006, the industry employed more than 7 million Americans. But between 2007 and 2009, construction employment fell by 1.5 million—to its lowest level since 1998. The industry has bounced back since as the economic recovery progresses: The National Association of Homebuilders estimates that [...]

September 9th, 2016|The Atlantic|

Stacked up against 2009 wages, paychecks smaller

If your paycheck still feels smaller than it was before the economic crisis, that’s because it is. More than seven years after the Great Recession, most Massachusetts workers are just starting to see a rebound in their wages. And for many, despite raises and stronger job growth, paychecks haven’t quite climbed back to their peaks, [...]

September 4th, 2016|The Boston Globe|

Pfizer to acquire Medivation for $14 billion

Pharmaceutical giant Pfizer announced Monday that it has agreed to acquire Medivation in a $14 billion deal that would add a blockbuster drug to its cancer pipeline. Medivation, a San Francisco biopharmaceutical company, has been highly sought after in recent months. Its flagship product, Xtandi, is a prostate cancer treatment that generated $2.2 billion in sales over [...]

August 22nd, 2016|The Washington Post|